GC
AGN

Gratry & Company’s Allergan plc AGN Stock Holding History

Gratry & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,533
Closed -$1.13M – 99
2017
Q3 		$1.13M Sell
5,533
-4,180
-43% -$972K 1.39% 29
2017
Q2 		$2.36M Buy
9,713
+3,692
+61% +$868K 2.9% 9
2017
Q1 		$1.44M Buy
+6,021
New +$1.4M 1.76% 24
2016
Q4 		– Sell
-14,491
Closed -$3.34M – 92
2016
Q3 		$3.34M Sell
14,491
-39
-0.3% -$9.53K 2.6% 21
2016
Q2 		$3.36M Sell
14,530
-1,436
-9% -$331K 2.64% 21
2016
Q1 		$4.28M Buy
15,966
+4,795
+43% +$1.37M 3.06% 13
2015
Q4 		$3.49M Sell
11,171
-14,815
-57% -$4.41M 2.27% 24
2015
Q3 		$7.06M Sell
25,986
-1,588
-6% -$488K 4.34% 2
2015
Q2 		$8.37M Buy
27,574
+2,461
+10% +$734K 4.38% 3
2015
Q1 		$7.47M Buy
+25,113
New +$7.16M 4.04% 3
2014
Q4 		– Sell
-27,595
Closed -$6.66M – 83
2014
Q3 		$6.66M Sell
27,595
-5,020
-15% -$1.12M 3.49% 8
2014
Q2 		$7.28M Sell
32,615
-1,780
-5% -$369K 2.86% 19
2014
Q1 		$7.08M Buy
+34,395
New +$6.81M 2.55% 21

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Gratry & Company's AGN Position: Q4 2017 in Review

Gratry & Company sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 5,533 shares — an estimated $1.13M sold.

Gratry & Company first reported a position in AGN in Q1 2014 and held it in 13 quarters. The position peaked at $8.37M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Gratry & Company reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Gratry & Company sold 5,533 Allergan plc shares in Q4 2017, an estimated $1.13M.
  • Gratry & Company first reported a position in Allergan plc in Q1 2014 and held it in 13 quarters.
  • Gratry & Company's Allergan plc position peaked at $8.37M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Gratry & Company's 13F filing for Q4 2017, filed 5 Feb 2018.